4月29日,长江生命科技(00775)早盘涨超8%,高见1.01港元,本月内累计涨幅已超85%。截至发稿,股价报1港元,成交额3010.10万港元。公司旗下针对TROP2的新型癌症疫苗在临床前测试中取得良好成果,并已向香港及美国提交相关专利申请。公司认为,该疫苗成功商品化后将带来重大经济效益。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.